51,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Melanotransferrin (melanoma tumour antigen p97) is an iron- binding transferrin homologue expressed at high levels on melanoma tumours and at lower levels on normal tissues. Unlike its relatives, transferrin and lactoferrin, melanotransferrin is membrane-bound. These properties suggest that melanotransferrin may assist melanoma and other tumour cell types with their increased requirement for iron. To address this hypothesis we utilised models including: (i) the melanotransferrin knockout mouse, and (ii) systematic down-regulation of melanotransferrin in melanoma cells using siRNA. Rigorous…mehr

Produktbeschreibung
Melanotransferrin (melanoma tumour antigen p97) is an
iron-
binding transferrin homologue expressed at high
levels on
melanoma tumours and at lower levels on normal
tissues. Unlike its
relatives, transferrin and lactoferrin,
melanotransferrin is
membrane-bound. These properties suggest that
melanotransferrin
may assist melanoma and other tumour cell types with
their increased requirement for iron. To address this
hypothesis we
utilised models including: (i) the melanotransferrin
knockout mouse, and (ii) systematic down-regulation of
melanotransferrin in melanoma cells using siRNA.
Rigorous
phenotypic
characterisation of this knockout mouse demonstrated no
differences in iron metabolism, behaviour or other
physiological parameters compared to wild-type
controls. In
melanoma cells, melanotransferrin was found to
facilitate
proliferation and
migration, and also to enhance tumourigenesis in nude
mice.
Moreover, whole genome array analysis of these models
in addition
to cell models of melanotransferrin over-expression
indicated
differences in genes associated with growth.
Autorenporträt
Doctor Louise Dunn is a National Health and Medical Research Council
Postdoctoral Fellow. Professor Des Richardson is a National
Health and Medical
Research Council Senior Principal Research Fellow and Director of
the Iron Metabolism
and Chelation program at the University of Sydney, Australia.